Cena / účetní hodnota společnosti Theratechnologies
Jaká je hodnota metriky Cena / účetní hodnota společnosti Theratechnologies?
Hodnota metriky Cena / účetní hodnota společnosti Theratechnologies, Inc. je -4.52
Jaká je definice metriky Cena / účetní hodnota?
Cena / učetní hodnota (Price to book ratio) je ukazatel, který vyjadřuje poměr mezi hodnotou společnosti a book value společnosti, což je hodnota čistých aktiv.
The price to book ratio, or P/B ratio, is a financial ratio used to compare a company's current market price to its book value. It is also sometimes known as a market to book ratio or price to equity ratio. The calculation of a price to book ratio can be performed in two ways. It can be calculated as the company's market capitalization divided by the company's total book value from its balance sheet. It can also be calculated using per-share values and dividing a company's current share price by the book value per share (i.e. its book value divided by the number of outstanding shares).
The P/B ratio varies between industries. The industries that require more infrastructure capital (for each dollar of profit) will usually trade at P/B ratios much lower than, for example, consulting firms. P/B ratios are commonly used to compare banks, because most assets and liabilities of banks are constantly valued at market values. A higher P/B ratio implies that investors expect management to create more value from a given set of assets, all else equal (and/or that the market value of the firm's assets is significantly higher than their accounting value).
P/B ratios do not, however, directly provide any information on the ability of the firm to generate profits or cash for shareholders. This ratio also gives some idea of whether an investor is paying too much for what would be left if the company went bankrupt immediately. For companies in distress, the book value is usually calculated without the intangible assets that would have no resale value. In such cases, P/B should also be calculated on a "diluted" basis, because stock options may well vest on sale of the company or change of control or firing of management.
Cena / účetní hodnota společností v sektoru Health Care sektor na TSX ve srovnání se společností Theratechnologies
Čemu se věnuje společnost Theratechnologies?
Theratechnologies Inc., a biopharmaceutical company, focuses on the development and commercialization of various therapies to address the unmet medical needs in the United States, Canada, and Europe. The company offers EGRIFTA and EGRIFTA SV, for the reduction of excess abdominal fat in human immunodeficiency virus (HIV)-infected patients with lipodystrophy; and Trogarzo, an injection refers to ibalizumab for the treatment of multidrug resistant HIV-1 infected patients. Its pipeline products include F8 Formulation for the treatment of lipodystrophy in people living with HIV; TH-1902 for the treatment of triple negative breast cancer; and TH-1904 for the treatment of ovarian cancer. The company was incorporated in 1993 and is headquartered in Montreal, Canada.
Firmy s metrikou cena / účetní hodnota podobnou společnosti Theratechnologies
- Hodnota metriky Cena / účetní hodnota společnosti Dine Brands Global Inc je -4.56
- Hodnota metriky Cena / účetní hodnota společnosti Intact Gold je -4.55
- Hodnota metriky Cena / účetní hodnota společnosti Sculptor Capital Management je -4.54
- Hodnota metriky Cena / účetní hodnota společnosti Predilife S.A je -4.54
- Hodnota metriky Cena / účetní hodnota společnosti The Bombay Dyeing and Manufacturing je -4.53
- Hodnota metriky Cena / účetní hodnota společnosti Sealand Capital Galaxy je -4.53
- Hodnota metriky Cena / účetní hodnota společnosti Theratechnologies je -4.52
- Hodnota metriky Cena / účetní hodnota společnosti Austral Resources Australia je -4.52
- Hodnota metriky Cena / účetní hodnota společnosti Jia limited je -4.50
- Hodnota metriky Cena / účetní hodnota společnosti Symbol Mining je -4.49
- Hodnota metriky Cena / účetní hodnota společnosti Orosur Mining je -4.48
- Hodnota metriky Cena / účetní hodnota společnosti Yum! Brands je -4.46
- Hodnota metriky Cena / účetní hodnota společnosti Rhinomed je -4.46